Bichen Pharmaceutical

company

About

Bichen Pharmaceutical is a small-molecule tumor-targeted drug developer for the treatment of various malignant tumors and brain metastases.

  • 51 - 100

Details

Last Funding Type
Series B
Last Funding Money Raised
$30M
Industries
Biopharma,Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 2015
Number Of Employee
51 - 100
Operating Status
Active

Bichen Pharmaceutical is a small-molecule tumor-targeted drug developer for the treatment of various malignant tumors and brain metastases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$30M
Bichen Pharmaceutical has raised a total of $30M in funding over 2 rounds. Their latest funding was raised on Jan 4, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 4, 2022 Series B $30M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Bichen Pharmaceutical is funded by 1 investors. Tongde Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Tongde Capital Series B